Skip to main content

HTG Molecular Diagnostics, Inc

HTGMDelisted Jul 10, 2023
Industry
Laboratory Analytical Instruments
SEC CIK
0001169987

HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding HTG Molecular Diagnostics, Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of HTGM: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders19110−8
SharesConverted for a 1-for-12 split38.7K0.0816.5K−22.1K (−57.3%)
Value$283.0K$0$66.2K−$216.8K (−76.6%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (0)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q4 2022 but not at the end of Q3 2022.

None.

Sold out (8)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of HTGM in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Renaissance Technologies LLC86,402$53.0K
Virtu Financial LLC72,452$44.0K
Vanguard Group Inc70,922$43.0K
Geode Capital Management, LLC47,178$28.0K
Susquehanna International Group, LLP27,456$17.0K
Millennium Management LLC23,683$15.0K
Two Sigma Securities, LLC21,666$13.0K
State Street Corp14,455$9.00K

Not filed for Q4 2022 yet (1)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HTGM in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Surevest, LLC1$0